Atlas Trials

Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat

Clinical trial NCT03946592 · COMPLETED

Trial details

NCT number
NCT03946592
Sponsor
Daewoong Pharmaceutical Co. LTD.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Submental Fat
Start date
2019-05-15
Primary completion
2020-07-02
Enrollment
148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.